Therapeutic adenine base editing of human hematopoietic stem cells
2023
Nature Communications
CRISPR-Cas9-mediated gene editing of the BCL11A enhancer for pediatric β(0)/β(0) transfusion-dependent β-thalassemia
2022
Nature Medicine
Non-viral, specifically targeted CAR-T cells achieve high safety and efficacy in B-NHL
2022
Nature
Therapeutic base editing of human hematopoietic stem cells
2020
Nature Medicine
Dual base editor catalyzes both cytosine and adenine base conversions in human cells
2020
Nature Biotechnology
Targeted, efficient sequence insertion and replacement in rice
2020
Nature Biotechnology
Highly efficient therapeutic gene editing of human hematopoietic stem cells
2019
Nature Medicine
Correction of a genetic disease by CRISPR-Cas9-mediated gene editing in mouse spermatogonial stem cells
2015
Cell Research
